Evaxion A (EVAX) EPS (Weighted Average and Diluted) (2021 - 2023)

Evaxion A (EVAX) reported EPS (Weighted Average and Diluted) of -$12354.3 for Q2 2023, down 16.6% on a YoY basis from -$14813.2 in Q2 2022, and down 16.6% quarter-over-quarter from -$10595.6 in Q2 2022.

Evaxion A (EVAX) EPS (Weighted Average and Diluted) (2021 - 2023) Analysis & Trends

Evaxion A has reported EPS (Weighted Average and Diluted) for 3 years, with the latest figure at -$12354.3 in Q2 2023.

  • For the quarter ending Q2 2023, EPS (Weighted Average and Diluted) fell 16.6% year-over-year to -$12354.3; the trailing twelve-month figure through Jun 2023 stood at -$12354.3 (down 16.6% YoY), and the FY2023 full-year result was -$0.81, up 17.35% from the prior year.
  • EPS (Weighted Average and Diluted) for Q2 2023 stood at -$12354.3, down from -$10595.6 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$10595.6 in Q2 2022, with the low at -$23164.0 in Q1 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$15093.4 across 3 years, with a median of -$12354.3 in 2023.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 8.32% in 2022 against a maximum downside of 30.17% in 2022.
  • Evaxion A's EPS (Weighted Average and Diluted) stood at -$11557.6 in 2021, then increased by 8.32% to -$10595.6 in 2022, then retreated by 16.6% to -$12354.3 in 2023.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$12354.3 (Q2 2023), -$10595.6 (Q2 2022), and -$23164.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.68
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.06
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3,086.42
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 0.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 4.02
9 Abivax 91.96 Bn 91.96 Bn - -0.61
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 6.75

Historic Data

Download Data
DateValue
Jun 30, 2023 -12,354.35
Jun 30, 2022 -10,595.56
Mar 31, 2022 -23,164.00
Jun 30, 2021 -11,557.63
Mar 31, 2021 -17,795.65